Search

Displaying results 8261 - 8270 of 10000 in total
  1. Drug

    Vesatolimod

    go.drugbank.com/drugs/DB12687
    Investigational

    Vesatolimod has been used in trials studying the treatment of Hepatitis B and Chronic Hepatitis B.

  2. Drug

    1-deoxymannojirimycin

    go.drugbank.com/drugs/DB03955
    Experimental

    An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]

  3. Drug

    Coenzyme A persulfide

    go.drugbank.com/drugs/DB04036
    Experimental

    Coenzyme A persulfide is a possible in vivo inhibitor of mammalian short chain acyl-CoA dehydrogenase.

  4. Drug

    AB-207

    go.drugbank.com/drugs/DB22801
    Investigational

    AB-207 is under investigation in clinical trial NCT06456073 (E-CEL UVEC Treatment for Anal Fissures).

    Synonyms: E-CEL UVE, E-CEL UVEC cells
  5. Drug

    Indium

    go.drugbank.com/drugs/DB11659
    Investigational

    Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.

  6. Drug

    Safingol

    go.drugbank.com/drugs/DB11924
    Investigational

    Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  7. Drug

    Oleandrin

    go.drugbank.com/drugs/DB12843
    Investigational

    Oleandrin has been used in trials studying the treatment of Lung Cancer and Chemotherapeutic Agent Toxicity.

  8. Drug

    Alcuronium

    go.drugbank.com/drugs/DB13648
    Experimental

    It is used as an anesthesia adjuvant.

    Synonyms: N,N'-Diallylnortoxiferinium, N,N'-diallyl-bis-nor-toxiferine
  9. Drug

    Pradofloxacin

    go.drugbank.com/drugs/DB11453
    ExperimentalVet approved

    It was approved by the European Commission in April 2011 for bacterial infections in dogs and cats.

  10. Drug

    Inarigivir

    go.drugbank.com/drugs/DB15062
    Investigational

    Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis